Table 1.

Subject demographics and clinical information.

	RmTLE (n = 32)	LmTLE (n = 15)	Controls (n = 96)	P-value
Age (years)	41.1 ± 11.7	37.1 ± 14.4	37.9 ± 13.4	0.34a
Gender (M/F)	15/17	10/5	50/46	0.45a
Duration of epilepsy (years)	20.0 ± 15.0b	23.2 ± 16.7		0.51c
MTS on MRI	19 (59%)	14 (93%)		0.02d,c
MTS or mesial temporal gliosis from pathology	28 (97%)e	14 (100%)f		0.51c
PET hypometabolism localization	27 (84%)	12 (80%)		0.72c
Interictal EEG localization	26 (81%)	9 (60%)		0.13c
Ictal EEG localization	27 (84%)	14 (93%)		0.41c
Had SEEG study	4 (13%)	0 (0%)		0.16c
Presence of FBTCS	15 (47%)	10 (67%)		0.22c

^aKruskal-Wallis test.

^bOne RmTLE patient’s duration of epilepsy is unknown and was not included (n = 31).

^cWilcoxon rank-sum test.

^d P < 0.05.

^eThree RmTLE patients did not have a postoperative pathology specimen (n = 29).

^fOne LmTLE patient did not have a postoperative pathology specimen (n = 14).